BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/11/2025 5:40:42 AM | Browse: 21 | Download: 3
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 112981
Country China
Category Oncology
Manuscript Type Retrospective Study
Article Title Survival prognosis in advanced HER-2 negative gastric cancer treated with immunochemotherapy: A novel model
Manuscript Source Invited Manuscript
All Author List Zhi-Yuan Yao, Gang Bao, Geng-Chen Li, Qiu-Lin Hao, Li-Jie Ma, Yue-Xuan Rao, Ke Xu, Xiao Ma and Zheng-Xiang Han
Funding Agency and Grant Number
Corresponding Author Zheng-Xiang Han, PhD, Professor, Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Xuzhou 221000, Jiangsu Province, China. xzpxlgc@163.com
Key Words Gastric cancer; Programmed death-1 inhibitor; Predictive model; Neutrophil-to-lymphocyte ratio; C-reactive protein-albumin-lymphocyte index; Efficacy
Core Tip This study developed and validated a novel survival prediction model for advanced HER-2 negative gastric cancer patients receiving immunotherapy combined with chemotherapy. A retrospective analysis of 200 patients identified programmed death ligand 1 expression, microsatellite instability, tumor-node-metastasis stage, tumor differentiation, neutrophil-to-lymphocyte ratio, and C-reactive protein-albumin-lymphocyte index as independent prognostic factors. Based on these factors, nomogram models for progression-free survival and overall survival were constructed and validated using the concordance index (C-index) and area under the curve. The results showed good discrimination ability in both the training and validation sets, indicating that the model effectively predicts patient survival outcomes and provides strong support for personalized treatment decisions.
Citation Yao ZY, Bao G, Li GC, Hao QL, Ma LJ, Rao YX, Xu K, Ma X, Han ZX. Survival prognosis in advanced HER-2 negative gastric cancer treated with immunochemotherapy: A novel model. World J Gastrointest Oncol 2025; In press
Received
2025-08-12 06:26
Peer-Review Started
2025-08-12 06:29
To Make the First Decision
Return for Revision
2025-08-22 08:35
Revised
2025-08-30 16:55
Second Decision
2025-10-11 02:46
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-10-11 05:40
Articles in Press
2025-10-11 05:40
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com